RATIONALE: Indirect airway hyperresponsiveness (AHR) is a fundamental feature of asthma that is manifest as exercise-induced bronchoconstriction (EIB). Secreted phospholipase A2 group X (sPLA2-X) plays a key role in regulating eicosanoid formation and the development of inflammation and AHR in murine models. OBJECTIVES: We sought to examine sPLA2-X in the airway epithelium and airway wall of patients with asthma, the relationship to AHR in humans, and the regulation and function of sPLA2-X within the epithelium. METHODS: We precisely phenotyped 34 patients with asthma (19 with and 15 without EIB) and 10 normal control subjects to examine in vivo differences in epithelial gene expression, quantitative morphometry of endobronchial biopsies, and levels of secreted protein. The regulation of sPLA2-X gene (PLA2G10) expression was examined in primary airway epithelial cell cultures. The function of epithelial sPLA2-X in eicosanoid formation was examined using PLA2 inhibitors and murine tracheal epithelial cells with Pla2g10 deletion. MEASUREMENTS AND MAIN RESULTS: We found that sPLA2-X protein is increased in the airways of patients with asthma and that epithelial-derived sPLA2-X may be increased in association with indirect AHR. The expression of sPLA2-X increases during in vitro epithelial differentiation; is regulated by inflammatory signals including tumor necrosis factor, IL-13, and IL-17; and is both secreted from the epithelium and directly participates in the release of arachidonic acid by epithelial cells. CONCLUSIONS: These data reveal a relationship between epithelial-derived sPLA2-X and indirect AHR in asthma and that sPLA2-X serves as an epithelial regulator of inflammatory eicosanoid formation. Therapies targeting epithelial sPLA2-X may be useful in asthma.
RATIONALE: Indirect airway hyperresponsiveness (AHR) is a fundamental feature of asthma that is manifest as exercise-induced bronchoconstriction (EIB). Secreted phospholipase A2 group X (sPLA2-X) plays a key role in regulating eicosanoid formation and the development of inflammation and AHR in murine models. OBJECTIVES: We sought to examine sPLA2-X in the airway epithelium and airway wall of patients with asthma, the relationship to AHR in humans, and the regulation and function of sPLA2-X within the epithelium. METHODS: We precisely phenotyped 34 patients with asthma (19 with and 15 without EIB) and 10 normal control subjects to examine in vivo differences in epithelial gene expression, quantitative morphometry of endobronchial biopsies, and levels of secreted protein. The regulation of sPLA2-X gene (PLA2G10) expression was examined in primary airway epithelial cell cultures. The function of epithelial sPLA2-X in eicosanoid formation was examined using PLA2 inhibitors and murine tracheal epithelial cells with Pla2g10 deletion. MEASUREMENTS AND MAIN RESULTS: We found that sPLA2-X protein is increased in the airways of patients with asthma and that epithelial-derived sPLA2-X may be increased in association with indirect AHR. The expression of sPLA2-X increases during in vitro epithelial differentiation; is regulated by inflammatory signals including tumornecrosis factor, IL-13, and IL-17; and is both secreted from the epithelium and directly participates in the release of arachidonic acid by epithelial cells. CONCLUSIONS: These data reveal a relationship between epithelial-derived sPLA2-X and indirect AHR in asthma and that sPLA2-X serves as an epithelial regulator of inflammatory eicosanoid formation. Therapies targeting epithelial sPLA2-X may be useful in asthma.
Authors: Daniëlle M J Curfs; Stijn A I Ghesquiere; Monique N Vergouwe; Ingeborg van der Made; Marion J J Gijbels; David R Greaves; J Sjef Verbeek; Marten H Hofker; Menno P J de Winther Journal: J Biol Chem Date: 2008-05-28 Impact factor: 5.157
Authors: Teal S Hallstrand; Emil Y Chi; Alan G Singer; Michael H Gelb; William R Henderson Journal: Am J Respir Crit Care Med Date: 2007-09-27 Impact factor: 21.405
Authors: Simona Zarini; Miguel A Gijón; Aaron E Ransome; Robert C Murphy; Angelo Sala Journal: Proc Natl Acad Sci U S A Date: 2009-05-04 Impact factor: 11.205
Authors: Teal S Hallstrand; Mark M Wurfel; Ying Lai; Zhanglin Ni; Michael H Gelb; William A Altemeier; Richard P Beyer; Moira L Aitken; William R Henderson Journal: PLoS One Date: 2010-01-05 Impact factor: 3.240
Authors: Ying Lai; William A Altemeier; John Vandree; Adrian M Piliponsky; Brian Johnson; Cara L Appel; Charles W Frevert; Dallas M Hyde; Steven F Ziegler; Dirk E Smith; William R Henderson; Michael H Gelb; Teal S Hallstrand Journal: J Allergy Clin Immunol Date: 2013-11-09 Impact factor: 10.793
Authors: Herbert Luke Ogden; Ying Lai; James D Nolin; Dowon An; Charles W Frevert; Michael H Gelb; William A Altemeier; Teal S Hallstrand Journal: J Immunol Date: 2020-04-27 Impact factor: 5.422
Authors: Teal S Hallstrand; Ying Lai; Kathryn A Hooper; Rob C Oslund; William A Altemeier; Gustavo Matute-Bello; Michael H Gelb Journal: J Allergy Clin Immunol Date: 2015-06-30 Impact factor: 10.793
Authors: James D Nolin; Ying Lai; Herbert Luke Ogden; Anne M Manicone; Ryan C Murphy; Dowon An; Charles W Frevert; Farideh Ghomashchi; Gajendra S Naika; Michael H Gelb; Gail M Gauvreau; Adrian M Piliponsky; William A Altemeier; Teal S Hallstrand Journal: JCI Insight Date: 2017-11-02
Authors: James D Nolin; Ryan C Murphy; Michael H Gelb; William A Altemeier; William R Henderson; Teal S Hallstrand Journal: Biochim Biophys Acta Mol Cell Biol Lipids Date: 2018-12-05 Impact factor: 4.698
Authors: James D Nolin; H Luke Ogden; Ying Lai; William A Altemeier; Charles W Frevert; James G Bollinger; Gajendra S Naika; Anthony Kicic; Stephen M Stick; Gerard Lambeau; William R Henderson; Michael H Gelb; Teal S Hallstrand Journal: Am J Respir Cell Mol Biol Date: 2016-12 Impact factor: 6.914